We are using a tool called QtNGS (quantitative targeted amplicon-based next-generation sequencing ) to measure the abundance of local pathogens in patients with ventilator-associated lower respiratory tract infections. We hypothesize that changes in pathogen abundance before and after treatment are related to patient outcomes. This study aims to evaluate the effectiveness of the tool by analyzing the changes in pathogen abundance and exploring the relationship between these changes and clinical outcomes.
Study Type
OBSERVATIONAL
Enrollment
200
We will perform bronchoscopy and collect bronchoalveolar lavage fluid (BALF) samples at the time of patient enrollment and three days after the treatment.
he First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
RECRUITING28-day Mortality Rate
The 28-day mortality rate will be measured to determine the percentage of patients who die within 28 days of study enrollment. This outcome will help assess the effectiveness of QtNGS in evaluating early microbiological response.
Time frame: 28 day after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.